Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
Revance Therapeutics, Inc. (RVNC)
Last revance therapeutics, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.revance.com
Company Research
Source: Seeking Alpha
Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript Revance Therapeutics, Inc. (NASDAQ: RVNC Company Participants Jeanie Herbert - Senior Director, IR & Corporate Communications Daniel Browne - Co-Founder, President, CEO & Director Tobin Schilke - CFO & Principal Accounting Officer Dustin Sjuts - Head, Commercial, Aesthetics & Therapeutics Abhay Joshi - COO Conference Call Participants Seamus Fernandez - Guggenheim Securities Annabel Samimy - Stifel, Nicolaus & Company Kenneth Cacciatore - Cowen and Company David Amsellem - Piper Jaffray Companies Douglas Tsao - H.C. Wainwright & Co. Myles Minter - William Blair & Company Alexander Lim - Mizuho Americas Operator Welcome to the Revance Therapeutics First Quarter 2019 Financial Results and Corporate Update Conference Call. [Operator Instructions]. As a reminder, this call is being recorded today, May 8, 2019. I would now like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Rela
Show less
Read more
Impact Snapshot
Event Time:
RVNC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVNC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVNC alerts
High impacting Revance Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
RVNC
News
- Revance Therapeutics, Inc. (NASDAQ: RVNC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Revance Therapeutics ticks higher as holder says Crown deal undervalues company [Seeking Alpha]Seeking Alpha
- REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNCBusiness Wire
- Shareholder Alert: Ademi LLP Investigates Whether Revance Therapeutics, Inc. Is Obtaining a Fair Price for Its Public ShareholdersBusiness Wire
- Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share [Yahoo! Finance]Yahoo! Finance
RVNC
Earnings
- 8/8/24 - Beat
RVNC
Sec Filings
- 12/19/24 - Form SCHEDULE
- 12/12/24 - Form SC
- 12/12/24 - Form SC
- RVNC's page on the SEC website